Literature DB >> 9596467

Cigarette smoking and the colorectal adenoma-carcinoma sequence: a hypothesis to explain the paradox.

M B Terry1, A I Neugut.   

Abstract

As recognized precursor lesions to colorectal cancer, colorectal adenomatous polyps have been studied to enhance knowledge of colorectal cancer etiology. Although most of the known risk factors for colorectal cancer are also associated with the occurrence of colorectal adenomas, cigarette smoking has had a strong, consistent relationship with colorectal adenomas but is generally not associated with colorectal cancer. The explanation for this paradox is unknown. With data collected in 1986-1988 during a large case-control study based on colonoscopy results in New York City, New York, the authors investigated the possibility that the paradox may arise because subjects with colorectal adenomas were included in the control group of cancer case-control studies. The authors found a statistically significant increased risk between heavy cigarette smoking (smokers with > or = 40 pack-years of smoking) and risk of adenoma (odds ratio (OR) = 1.61, 95% confidence interval (CI) 1.06-2.44). They saw no increased colorectal cancer risk from heavy cigarette smoking (OR = 1.02, 95% CI 0.52-1.99) using a "manufactured" control group to simulate a typical unscreened, population-based control group. When the authors compared these colorectal cancer cases with an adenoma-free control group examined by colonoscopy in a polytomous model with several case groups (newly diagnosed adenomas, carcinoma in situ, intramucosal carcinoma, and colorectal cancer), they found that the risk for 20-39 pack-years of smoking was elevated, although not statistically significant, and was similar for all four case groups. The risk for the highest smoking category (> or = 40 pack-years) was more strongly elevated in all four case groups, although it was statistically significant for only the newly diagnosed adenoma and the carcinoma in situ cases (adenomas, OR = 1.59, 95% CI 1.05-2.42; carcinoma in situ, OR = 2.05, 95% CI 1.01-4.15; intramucosal carcinoma, OR = 1.30, 95% CI 0.61-2.77; and colorectal cancer, OR = 1.30, 95% CI 0.64-2.65). While the authors' study is weakened by the lack of statistical significance concerning risk for colorectal cancer, these data offer some support for the hypothesis that the association between cigarette smoking and risk of colorectal cancer may have been masked by inclusion in the control group of subjects with adenomas. They also suggest that the major effect of smoking on the colorectal adenoma-carcinoma sequence occurs in the earlier stages of the formation of adenoma and the development of carcinoma in situ.

Entities:  

Mesh:

Year:  1998        PMID: 9596467     DOI: 10.1093/oxfordjournals.aje.a009379

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  14 in total

1.  The effect of secondhand smoke exposure on the association between active cigarette smoking and colorectal cancer.

Authors:  Luke J Peppone; Mary E Reid; Kirsten B Moysich; Gary R Morrow; Pascal Jean-Pierre; Supriya G Mohile; Tom V Darling; Andrew Hyland
Journal:  Cancer Causes Control       Date:  2010-04-08       Impact factor: 2.506

2.  Factors that increase risk of colon polyps.

Authors:  Sarah W Grahn; Madhulika G Varma
Journal:  Clin Colon Rectal Surg       Date:  2008-11

3.  N-Acetyltransferase polymorphism and human cancer risk.

Authors:  X Yang; T Takeshita; K Morimoto
Journal:  Environ Health Prev Med       Date:  2000-01       Impact factor: 3.674

4.  APC and KRAS mutations in distal colorectal polyps are related to smoking habits in men: results of a cross-sectional study.

Authors:  Fernando Martínez; Carlos Fernández-Martos; María Jesús Quintana; Antoni Castells; Antonio Llombart; Francisco Ińiguez; Vicente Guillem; Francisco Dasí
Journal:  Clin Transl Oncol       Date:  2011-09       Impact factor: 3.405

Review 5.  Polycyclic aromatic hydrocarbons and digestive tract cancers: a perspective.

Authors:  Deacqunita L Diggs; Ashley C Huderson; Kelly L Harris; Jeremy N Myers; Leah D Banks; Perumalla V Rekhadevi; Mohammad S Niaz; Aramandla Ramesh
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2011-10       Impact factor: 3.781

6.  Precursors in cancer epidemiology: aligning definition and function.

Authors:  Sholom Wacholder
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04       Impact factor: 4.254

7.  Colorectal polyp type and the association with charred meat consumption, smoking, and microsomal epoxide hydrolase polymorphisms.

Authors:  Andrea N Burnett-Hartman; Polly A Newcomb; Margaret T Mandelson; Scott V Adams; Karen J Wernli; Mazyar Shadman; Michelle A Wurscher; Karen W Makar
Journal:  Nutr Cancer       Date:  2011       Impact factor: 2.900

8.  Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics.

Authors:  Daniel D Buchanan; Kevin Sweet; Musa Drini; Mark A Jenkins; Aung Ko Win; Dallas R English; Michael D Walsh; Mark Clendenning; Diane M McKeone; Rhiannon J Walters; Aedan Roberts; Sally-Ann Pearson; Erika Pavluk; John L Hopper; Michael R Gattas; Jack Goldblatt; Jill George; Graeme K Suthers; Kerry D Phillips; Sonja Woodall; Julie Arnold; Kathy Tucker; Amanda Muir; Michael Field; Sian Greening; Steven Gallinger; Renee Perrier; John A Baron; John D Potter; Robert Haile; Wendy Frankel; Albert de la Chapelle; Finlay Macrae; Christophe Rosty; Neal I Walker; Susan Parry; Joanne P Young
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

9.  The Influence of Screening for Precancerous Lesions on Family-Based Genetic Association Tests: An Example of Colorectal Polyps and Cancer.

Authors:  Stephanie L Schmit; Jane C Figueiredo; Victoria K Cortessis; Duncan C Thomas
Journal:  Am J Epidemiol       Date:  2015-08-24       Impact factor: 4.897

Review 10.  The epidemiology and pathogenesis of neoplasia in the small intestine.

Authors:  David Schottenfeld; Jennifer L Beebe-Dimmer; Fawn D Vigneau
Journal:  Ann Epidemiol       Date:  2009-01       Impact factor: 3.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.